Advertisement
News
Advertisement

Sierra Leone: Another Top Doctor Dies from Ebola

Wed, 08/13/2014 - 9:21am
Clarence Roy-Macaulay and Maria Cheng - Associted Press - Associted Press
In this photo taken on Sunday, July 27, 2014, medical personnel work at the Doctors Without Borders facility in Kailahun, Sierra Leone where Dr. Sheik Humarr Khan died. Khan, a leading doctor who risked his own life to treat dozens of Ebola patients, died Tuesday, July 29, 2014, from the disease, officials said. Another doctor in Sierra Leone, Modupeh Cole, died on Wednesday, according to Sidie Yayah Tunis, director of communications for the Ministry of Health and Sanitation. (AP Photo/Youssouf Bah)A leading physician in Sierra Leone's fight against Ebola has died from the disease, an official said Wednesday, as it emerged that another top doctor had been considered to receive an experimental drug but did not get it and later died.
 
Ebola has killed more than 1,000 people in the current West African outbreak that has also hit Guinea, Liberia and Nigeria. Many of the dead are health workers, who are often working with inadequate supplies and protection. But despite the large number of deaths and infections among Africans, only two Americans and a Spaniard have received ZMapp, the unproven and experimental anti-Ebola drug made in the United States. That has stoked debate about ethics on who should be given the limited experimental treatment.
 
Doctors considered giving ZMapp to Sheik Humarr Khan, the chief doctor treating Ebola in Sierra Leone who had come down with the dreaded disease, but eventually decided against it, officials at the World Health Organization said in an email to The Associated Press on Wednesday.
 
WHO then tried to airlift Khan out of the country, but "his condition had deteriorated too much to be transported safely." He died July 29.
 
Doses of ZMapp for two Liberian doctors could arrive as soon as Wednesday in Liberia, according to Liberian Health Minister Walter Gwenigale. They would be the first Africans known to receive the treatment.
 
The California-based company that makes the drug, Mapp Pharmaceuticals, has said that its supplies are now exhausted, and it would take months to make even a modest amount.
 
Canada announced Tuesday it would donate 800 to 1,000 doses of its experimental Ebola vaccine developed by the Public Health Agency of Canada to the World Health Organization.
 
"The trouble is, of course, with this very, very limited number of vaccines, who would you give that to?" said Dr. Gregory Taylor, deputy head of the agency.
 
He said the agency has been advised that it makes the most sense to give the vaccine to health care workers in Africa who are among the most vulnerable because of their close contact with Ebola patients
 
Meanwhile, yet another doctor in Sierra Leone, Modupeh Cole, died on Wednesday, according to Sidie Yayah Tunis, director of communications for the Ministry of Health and Sanitation. Cole, trained in the U.S., was one of the top doctors working in the Ebola isolation ward in Connaught Hospital in Freetown, the capital. He tested positive for the disease last week and was transferred to the eastern district of Kailahun, where Doctors Without Borders is running a treatment center.
 
Cole's sickness spread fear throughout the hospital where he worked, and staff there went on strike Friday and Saturday after learning that he had tested positive for the deadly disease. They returned to work on Sunday.
 
Both Cole's and Khan's deaths are a major blow to Sierra Leone's health system, which is struggling to cope with the deadly outbreak.
 
The outbreak, which was first identified in March in Guinea, has strained the resources of the poor West African countries it has hit and of the international community, which is struggling to mobilize enough qualified doctors.
 
There is no known cure or licensed treatment for Ebola.
 
---
 
Cheng reported from London. Associated Press writer Jonathan Paye-Layleh contributed from Monrovia, Liberia.
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading